{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T14:05:54Z","timestamp":1726495554335},"reference-count":66,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.leukres.2011.05.037","type":"journal-article","created":{"date-parts":[[2011,7,5]],"date-time":"2011-07-05T07:58:45Z","timestamp":1309852725000},"page":"1279-1285","source":"Crossref","is-referenced-by-count":9,"title":["The two faces of myeloproliferative neoplasms: Molecular events underlying lymphoid transformation"],"prefix":"10.1016","volume":"35","author":[{"given":"Ailsa","family":"Holroyd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas C.P.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald H.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2011.05.037_bib0005","series-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"68","article-title":"Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB and FGFR1","author":"Bain","year":"2008"},{"key":"10.1016\/j.leukres.2011.05.037_bib0010","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3324\/haematol.2009.021675","article-title":"Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1","volume":"95","author":"Bain","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2011.05.037_bib0015","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/leu.2008.287","article-title":"Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias","volume":"22","author":"Gotlib","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.05.037_bib0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.blre.2009.01.001","article-title":"classification, and therapy of eosinophilia and eosinophil disorders","volume":"23","author":"Valent","year":"2009","journal-title":"Blood Rev"},{"key":"10.1016\/j.leukres.2011.05.037_bib0025","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.leu.2404662","article-title":"Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma","volume":"21","author":"Metzgeroth","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.05.037_bib0030","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2011.05.037_bib0035","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2141.2008.07294.x","article-title":"Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: a phase-II study","volume":"143","author":"Metzgeroth","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2011.05.037_bib0040","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1182\/blood-2006-10-050054","article-title":"Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia","volume":"109","author":"Jovanovic","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.05.037_bib0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000046641","article-title":"Myeloproliferative disorders with translocations of chromosome 5q31\u201335: role of the platelet-derived growth factor receptor Beta","volume":"107","author":"Steer","year":"2002","journal-title":"Acta Haematol"},{"key":"10.1016\/j.leukres.2011.05.037_bib0050","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","article-title":"Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation","volume":"77","author":"Golub","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2011.05.037_bib0055","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMoa020150","article-title":"Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta","volume":"347","author":"Apperley","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2011.05.037_bib0060","first-page":"1628","article-title":"A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review","volume":"9","author":"Macdonald","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.05.037_bib0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000046639","article-title":"The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1","volume":"107","author":"Macdonald","year":"2002","journal-title":"Acta Haematol"},{"key":"10.1016\/j.leukres.2011.05.037_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2010.05.009","article-title":"B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene","author":"Baldazzi","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2011.05.037_bib0075","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1182\/blood-2007-02-074286","article-title":"Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome","volume":"110","author":"Chase","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.05.037_bib0080","doi-asserted-by":"crossref","first-page":"14479","DOI":"10.1073\/pnas.0404438101","article-title":"PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder","volume":"101","author":"Chen","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2011.05.037_bib0085","doi-asserted-by":"crossref","unstructured":"Wasag B, Lierman E, Meeus P, Cools J, Vandenberghe P. The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia\/lymphoma and t(7;8)(q22;p11). haematologica 2011;96:922\u201326.","DOI":"10.3324\/haematol.2010.036558"},{"key":"10.1016\/j.leukres.2011.05.037_bib0090","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.semcdb.2008.07.002","article-title":"JAKs in pathology: role of Janus kinases in hematopoietic malignancies and immunodeficiencies","volume":"19","author":"Vainchenker","year":"2008","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.leukres.2011.05.037_bib0095","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-0609.2010.01428.x","article-title":"Chromosome 9p24 abnormalities: prevalence, description of novel JAK2 translocations, JAK2V617F mutation analysis and clinicopathologic correlates","volume":"84","author":"Patnaik","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.leukres.2011.05.037_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2010.05.031","article-title":"Novel JAK2 rearrangement resulting from a t(9;22)(p24;q11.2) in B-acute lymphoblastic leukemia","author":"Tirado","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2011.05.037_bib0105","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.278.5341.1309","article-title":"A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia","volume":"278","author":"Lacronique","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.leukres.2011.05.037_bib0110","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood.V90.7.2535","article-title":"Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia","volume":"90","author":"Peeters","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.05.037_bib0115","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/gcc.20585","article-title":"Novel SSBP2-JAK2 fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemia","volume":"47","author":"Poitras","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2011.05.037_bib0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.leu.2404948","article-title":"JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials","volume":"22","author":"Pardanani","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.05.037_bib0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2010.08457.x","article-title":"Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia","volume":"153","author":"Ernst","year":"2011","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.leukres.2011.05.037_bib0130","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3324\/haematol.2009.008094","article-title":"A novel dasatinib-sensitive RCSD1-ABL1 fusion transcript in chemotherapy-refractory adult pre-B lymphoblastic leukemia with t(1;9)(q24;q34)","volume":"94","author":"Mustjoki","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2011.05.037_bib0135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/gcc.20541","article-title":"The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1","volume":"47","author":"Hidalgo-Curtis","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2011.05.037_bib0140","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/gcc.20743","article-title":"ABL1 rearrangements in T-cell acute lymphoblastic leukemia","volume":"49","author":"Hagemeijer","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2011.05.037_bib0145","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/sj.leu.2405033","article-title":"Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocation","volume":"22","author":"Soler","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.05.037_bib0150","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3324\/haematol.2009.016345","article-title":"Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis","volume":"95","author":"Erben","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2011.05.037_bib0155","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1182\/blood.V99.5.1776","article-title":"Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13)","volume":"99","author":"Cools","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.05.037_bib0160","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1182\/blood.V90.8.3130","article-title":"Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement","volume":"90","author":"Aguiar","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.05.037_bib0165","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1182\/blood.V99.10.3857","article-title":"NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15)","volume":"99","author":"Rosati","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.05.037_bib0170","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/(SICI)1098-2264(199911)26:3<192::AID-GCC2>3.0.CO;2-E","article-title":"Fusion of TEL\/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute myelogenous leukemia with t(5;12)(q31;p13)","volume":"26","author":"Yagasaki","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2011.05.037_bib0175","first-page":"3592","article-title":"Fusion of H4\/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21)","volume":"60","author":"Kulkarni","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2011.05.037_bib0180","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1007\/s00018-004-4272-z","article-title":"Oncogenic derivatives of platelet-derived growth factor receptors","volume":"61","author":"Jones","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.leukres.2011.05.037_bib0185","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/leu.2008.309","article-title":"Detection and molecular monitoring of FIP1L1-PDGFRA-positive disease by analysis of patient-specific genomic DNA fusion junctions","volume":"23","author":"Score","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.05.037_bib0190","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/sj.leu.2404728","article-title":"A novel ETV6-PDGFRB fusion transcript missed by standard screening in a patient with an imatinib responsive chronic myeloproliferative disease","volume":"21","author":"Curtis","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.05.037_bib0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.2007.06628.x","article-title":"Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia","volume":"138","author":"Curtis","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2011.05.037_bib0200","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/gcc.20359","article-title":"Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion gene","volume":"45","author":"Walz","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2011.05.037_bib0205","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/hmg\/11.12.1391","article-title":"The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA","volume":"11","author":"Baxter","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.leukres.2011.05.037_bib0210","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/sj.leu.2404154","article-title":"Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia","volume":"20","author":"Score","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.05.037_bib0215","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2002-10-3103","article-title":"Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders","volume":"101","author":"Pardanani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.05.037_bib0220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ceb.2009.02.005","article-title":"Kinome signaling through regulated protein\u2013protein interactions in normal and cancer cells","volume":"21","author":"Pawson","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.leukres.2011.05.037_bib0225","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000101707","article-title":"Chronic myeloproliferative disorders: the role of tyrosine kinases in pathogenesis, diagnosis and therapy","volume":"74","author":"Macdonald","year":"2007","journal-title":"Pathobiology"},{"key":"10.1016\/j.leukres.2011.05.037_bib0230","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1073\/pnas.0601192103","article-title":"Activation of FIP1L1-PDGFRalpha requires disruption of the juxtamembrane domain of PDGFRalpha and is FIP1L1-independent","volume":"103","author":"Stover","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2011.05.037_bib0235","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood.V85.7.1881.bloodjournal8571881","article-title":"A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia\/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity","volume":"85","author":"Inhorn","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.05.037_bib0240","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e31814b226e","article-title":"t(8;13)-positive bilineal lymphomas: report of 6 cases","volume":"32","author":"Vega","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.leukres.2011.05.037_bib0245","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1242\/dev.126.14.3131","article-title":"Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage","volume":"126","author":"Anderson","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.leukres.2011.05.037_bib0250","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1535-6108(04)00053-4","article-title":"Distinct stem cell myeloproliferative\/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations","volume":"5","author":"Roumiantsev","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2011.05.037_bib0255","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1182\/blood-2009-03-212704","article-title":"Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-fibroblast growth factor receptor-1 chimeric tyrosine kinase","volume":"114","author":"Ren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.05.037_bib0260","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1074\/jbc.M807489200","article-title":"FIP1L1-PDGFRalpha imposes eosinophil lineage commitment on hematopoietic stem\/progenitor cells","volume":"284","author":"Fukushima","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2011.05.037_bib0265","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/sj.leu.2401494","article-title":"The Tel-PDGFRbeta fusion gene produces a chronic myeloproliferative syndrome in transgenic mice","volume":"13","author":"Ritchie","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.05.037_bib0270","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1182\/blood.V93.5.1707","article-title":"TEL\/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor","volume":"93","author":"Tomasson","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.05.037_bib0275","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V95.6.2076","article-title":"Transforming properties of chimeric TEL-JAK proteins in Ba\/F3 cells","volume":"95","author":"Lacronique","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.05.037_bib0280","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1093\/emboj\/17.18.5321","article-title":"Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL\/JAK2 fusion genes","volume":"17","author":"Schwaller","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.leukres.2011.05.037_bib0285","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1182\/blood.V95.12.3891","article-title":"TEL-JAK2 transgenic mice develop T-cell leukemia","volume":"95","author":"Carron","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.05.037_bib0290","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1158\/0008-5472.CAN-04-4167","article-title":"Oncogenic tyrosine kinase of malignant hemopathy targets the centrosome","volume":"65","author":"Delaval","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2011.05.037_bib0295","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.molcel.2009.09.019","article-title":"Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes","volume":"36","author":"Choudhary","year":"2009","journal-title":"Mol Cell"},{"key":"10.1016\/j.leukres.2011.05.037_bib0300","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0140-6736(08)61341-0","article-title":"Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome","volume":"372","author":"Bercovich","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2011.05.037_bib0305","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1073\/pnas.0811761106","article-title":"JAK mutations in high-risk childhood acute lymphoblastic leukemia","volume":"106","author":"Mullighan","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2011.05.037_bib0310","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2009-03-208397","article-title":"Deregulated expression of cytokine receptor gene CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia","volume":"114","author":"Russell","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.05.037_bib0315","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.469","article-title":"Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia","volume":"41","author":"Mullighan","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.leukres.2011.05.037_bib0320","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1182\/blood-2009-08-235408","article-title":"Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group","volume":"115","author":"Hertzberg","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.05.037_bib0325","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1073\/pnas.0911726107","article-title":"Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia","volume":"107","author":"Yoda","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2011.05.037_bib0330","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2009-09-245944","article-title":"Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia","author":"Harvey","year":"2010","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611002736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611002736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T13:37:35Z","timestamp":1712583455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212611002736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0145212611002736"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2011.05.037","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}